Showing 2101-2110 of 3223 results for "".
- Eli Lilly Joins Race to Develop Coronavirus Treatmenthttps://modernod.com/news/eli-lilly-joins-race-to-develop-coronavirus-treatment/2477398/Pharmaceutical giant Eli Lilly & Co. has entered an agreement to develop an experimental therapy for the new coronavirus with with closely held biotechnology company AbCellera Biologics Inc., according to a Bloomberg
- AAO Provides Updated COVID-19 Guidance for Outpatient Clinics and Elective Surgeryhttps://modernod.com/news/aao-provides-updated-guidance-for-outpatient-clinics-and-elective-surgery/2477395/In response to the state of national emergency declared at the federal level, particularly as COVID-19 progresses in a given community, ophthalmologists should seriously consider both the intensity of clinic scheduling and the issue of elective surgeries, particularly in elderly patients and thos
- AGTC Announces Completion of Enrollment in All Adult Dose Groups of its Ongoing Phase 1/2 Clinical Trials in Patients with Achromatopsiahttps://modernod.com/news/agtc-announces-completion-of-enrollment-in-all-adult-dose-groups-of-its-ongoing-phase-1-2-clinical-trials-in-patients-with-achromatopsia/2477389/Applied Genetic Technologies Corporation (AGTC) announced that it has completed the planned enrollment in all dose groups for adult patients (age 18 years or older), including the two higher dose groups, of its phase 1/2 clinical programs with achromatopsia due to mutation in the
- Alirocumab May Cause Scleritis With Uveal Effusionhttps://modernod.com/news/alirocumab-may-cause-scleritis-with-uveal-effusion/2477386/The LDL-cholesterol-lowering agent alirocumab may cause scleritis with uveal effusion, according to the authors of a case report in Annals of Internal Medicine, as reported by Reuters. “Monoclonal antibody therapy is a relati
- Alcon Announces European Launch of Vivity Presbyopia-Correcting IOL With X-WAVE Technologyhttps://modernod.com/news/alcon-announces-european-launch-of-vivity-presbyopia-correcting-iol-with-x-wave-technology/2477377/Alcon announced that the AcrySof IQ Vivity IOL is now commercially available in select European markets, with additional countries to follow throughout 2020. The latest innovation in Alcon’s portfolio of presbyopia-correcting IOLs (PC-IOLs), Vivity is the first-of-its-kind, extended range
- Aldeyra Announces Strategic Prioritization of Late-Stage Clinical Pipeline in Ocular Diseasehttps://modernod.com/news/aldeyra-announces-strategic-prioritization-of-late-stage-clinical-pipeline-in-ocular-disease/2477378/Aldeyra Therapeutics announced strategic prioritization of late-stage ocular disease programs in allergic conjunctivitis, dry eye disease, and proliferative vitreoretinopathy. In conjunction with the strategic prioritization, Aldeyra appointed ophthalmology drug development expert James A. Gow, M
- Biogen, Eli Lilly, Takeda Ask Staff to Work From Home to Limit Coronavirus Spreadhttps://modernod.com/news/biogen-eli-lilly-takeda-ask-staff-to-work-from-home-to-limit-coronavirus-spread/2477367/Eli Lilly and Takeda have asked employees to work from home where possible to reduce the risk of coronavirus transmission in the wake of a number of people who attended a management meeting held by Biogen testing positive for SARS-CoV-2. The meeting was held late last month in Boston. Scot
- Jim Mazzo Receives the Ellis Island Medal of Honorhttps://modernod.com/news/jim-mazzo-receives-the-ellis-island-medal-of-honor/2477358/Jim Mazzo, Global President of Ophthalmic Devices with Carl Zeiss Meditec, has been chosen to receive the Ellis Island Medal of Honor in 2020. The Ellis Island Honors Society honors the importance of immigration to America’s prosperity and celebrates the contributions immigrants and their
- Alcon Launches Systane MyEyes to Increase Continuity of Care and Patient Retention Following iLUX MGD Treatmenthttps://modernod.com/news/alcon-launches-systane-myeyes-to-increase-continuity-of-care-and-patient-retention-following-ilux-mgd-treatment/2477353/Alcon has introduced Systane MyEyes, a new patient support program focused on increasing continuity of care and retention. It is the first-and-only comprehensive program focused on supporting and educating patients about the chronic and progressive nature of meibomian gland dysfunction (MGD) and
- Alcon Introduces Systane Hydration Preservative-Free Lubricant Eye Drops for Sensitive, Dry Eyeshttps://modernod.com/news/alcon-introduces-systane-hydration-preservative-free-lubricant-eye-drops-for-sensitive-dry-eyes/2477354/Alcon has introduced Systane Hydration Preservative-Free (PF) at the SECO International 2020 meeting (#SECO2020). Systane Hydration PF lubricant eye drops is a new preservative-free option for dry eye sufferers with sensitive eyes and those in need of long-lasting relief. It is used as a protecta